Skip to main content
Premium Trial:

Request an Annual Quote

Gabor Bethlendy, Peter Lassota

BioForce Nanosciences has named Gabor Bethlendy sales manager for Europe. He will be based in Boston, Mass.
Bethlendy joins BioForce from Combimatrix, where he was regional sales manager for the company’s custom microarray and array synthesizer product lines. Prior to that, Bethlendy was senior application scientist for Agilent Technologies.

Caliper Life Sciences last week said that it has appointed Peter Lassota as divisional vice president of oncology.
At Caliper, Lassota will lead the R&D activities involved in oncology applications and the utilization of biophotonic imaging for developing biomarker research technologies. Lassota joins Caliper from the Novartis Institutes for Biomedical Research, where he led Novartis’ US oncology pharmacology unit. Lassota has also worked at Wyeth-Ayerst Research and the American Cyanamid Company. He has an MS in chemistry from the University of Warsaw and a PhD in biochemistry and biophysics from the Polish Academy of Sciences.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.